,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2016-10-17 04:07:00,"Having freed itself of its volatile financial arm, GE Capital, the General Electric of today is stronger and leaner than ever.",0.9239791631698608,0.024087922647595406,0.05193290114402771,positive,0.8998912572860718
1,2016-10-17 04:07:00,"Through its seven core industrial business segments, GE gives you exposure to nearly every key industry, including healthcare, technology, aviation, oil and gas, transportation, manufacturing, automotive, and power.",0.06665511429309845,0.004797001834958792,0.9285478591918945,neutral,0.06185811385512352
2,2016-10-17 04:07:00,"There are many diversified companies out there, but it's hard to find one that has gained a solid footprint in each of its business segments.",0.4593343138694763,0.01246521808207035,0.5282004475593567,neutral,0.4468691051006317
3,2016-10-17 04:07:00,"While GE is now greatly exposed to cyclical industries, diversification should mitigate risks and keep the company sailing even during tough times.",0.9207273721694946,0.015179401263594627,0.06409329175949097,positive,0.9055479764938354
4,2016-10-17 04:07:00,"More important, GE is tapping aggressively into revolutionary future tech trends like the Internet of Things (IoT), big data, and 3D printing.",0.7001652717590332,0.011368527077138424,0.2884661853313446,positive,0.6887967586517334
5,2016-10-17 04:07:00,"With your grandkids likely to be living in a world dominated by these trends, GE is one of the best bets that you could make today.",0.18175308406352997,0.012875868938863277,0.8053710460662842,neutral,0.16887721419334412
6,2016-10-17 04:07:00,"In fact, GE truly is a ""digital industrial company,"" as it calls itself.",0.035167254507541656,0.006094643846154213,0.9587380290031433,neutral,0.029072610661387444
7,2016-10-17 04:07:00,"I believe a visionary management, innovative leadership, and opportunistic strategies are among GE's top strengths that should propel it to new heights in the decades to come.",0.8700729012489319,0.012800908647477627,0.11712611466646194,positive,0.8572719693183899
8,2016-10-17 04:07:00,"As GE grows, so should the returns on your investment for your grandkids.",0.38391369581222534,0.008999641053378582,0.6070866584777832,neutral,0.3749140501022339
9,2016-10-17 04:07:00,"George Budwell : With the average age across the globe continuing to rise, healthcare companies in general, and pharma companies in particular, should remain some of the most profitable businesses in the world for a long time to come.",0.8340387344360352,0.013239639811217785,0.1527215987443924,positive,0.8207991123199463
10,2016-10-17 04:07:00,"In this regard, top biopharmaceutical companies like Gilead Sciences (NASDAQ: GILD) come off as great stocks to buy for your grandkids.",0.4613424241542816,0.013802430592477322,0.5248550772666931,neutral,0.4475399851799011
11,2016-10-17 04:07:00,Gilead Sciences is a particularly intriguing name to buy right now for two reasons.,0.21572546660900116,0.01386252325028181,0.770412027835846,neutral,0.20186294615268707
12,2016-10-17 04:07:00,"First, this top biotech is trading at a steep discount relative to its earnings potential, with a rock-bottom forward price-to-earnings ratio of 6.3.",0.19389626383781433,0.11500675231218338,0.6910970211029053,neutral,0.07888951152563095
13,2016-10-17 04:07:00,"Although it is true that Gilead's core hepatitis C franchise is facing a number of significant competitive and political threats, the company still has plenty of time and resources to stave off a big hit to its top line within the next few years.",0.8214043378829956,0.11872518062591553,0.059870507568120956,positive,0.7026791572570801
14,2016-10-17 04:07:00,"Unfortunately, the market has grown increasingly impatient with management's rather careful approach on the mergers and acquisitions front, but that doesn't mean Gilead's top line is destined to crash next year, or even in 2018.",0.041346486657857895,0.8111777901649475,0.1474757343530655,negative,-0.7698312997817993
15,2016-10-17 04:07:00,"Second, the biotech does have a fairly robust and diverse clinical pipeline that's apparently being completely ignored by the market from a valuation standpoint at the moment.",0.0714840516448021,0.03266569972038269,0.8958502411842346,neutral,0.0388183519244194
16,2016-10-17 04:07:00,"Nevertheless, Gilead's plethora of exciting clinical candidates, such as the anti-inflammatory drug filgotinib and its variety of anticancer drug candidates, could generate billion in sales for the company in the not-so-distant future.",0.9173223376274109,0.014288273639976978,0.06838934123516083,positive,0.9030340909957886
17,2016-10-17 04:07:00,"All told, Gilead probably won't be a top-performing stock in the short term, but its strong track record of bringing game-changing new medications to market makes it worth buying as a long-term value play.",0.872296929359436,0.01559778954833746,0.1121053472161293,positive,0.8566991686820984
18,2016-10-17 04:07:00,"The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology.",0.07462237030267715,0.16781271994113922,0.757564902305603,neutral,-0.09319034963846207
19,2016-10-17 04:07:00,And we think its stock price has nearly unlimited room to run for early in-the-know investors!,0.28927910327911377,0.013621804304420948,0.6970990896224976,neutral,0.2756572961807251
20,2016-10-17 04:07:00,"To be one of them, just click here .",0.08918054401874542,0.07975278049707413,0.8310666680335999,neutral,0.009427763521671295
21,2016-10-17 04:07:00,George Budwell has no position in any stocks mentioned.,0.009733480401337147,0.03738681972026825,0.9528797268867493,neutral,-0.027653340250253677
22,2016-10-17 04:07:00,Jamal Carnette owns shares of General Electric.,0.015794742852449417,0.012034798040986061,0.9721704721450806,neutral,0.003759944811463356
23,2016-10-17 04:07:00,Neha Chamaria has no position in any stocks mentioned.,0.00990668311715126,0.05887661501765251,0.9312167167663574,neutral,-0.04896993190050125
24,2016-10-17 04:07:00,The Motley Fool owns shares of and recommends Gilead Sciences.,0.03258433938026428,0.013879264704883099,0.9535364508628845,neutral,0.01870507374405861
25,2016-10-17 04:07:00,The Motley Fool owns shares of General Electric and has the following options: short October 2016 $85 calls on Gilead Sciences.,0.018934808671474457,0.10906114429235458,0.8720040321350098,neutral,-0.09012633562088013
26,2016-10-17 04:07:00,The Motley Fool recommends Procter and Gamble.,0.049921534955501556,0.03660207241773605,0.9134764075279236,neutral,0.013319462537765503
27,2016-10-17 04:07:00,Try any of our Foolish newsletter services free for 30 days .,0.02325451746582985,0.013860778883099556,0.9628846645355225,neutral,0.009393738582730293
28,2016-10-17 04:07:00,"We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.",0.7942618727684021,0.015105843544006348,0.19063223898410797,positive,0.7791560292243958
29,2016-10-17 04:07:00,The Motley Fool has a disclosure policy .,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
30,2016-10-17 04:07:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.015637893229722977,0.9741575717926025,neutral,-0.0054333265870809555
